Autoimmune-associated congenital heart block: Treatment of the mother with immunoadsorption

Therapeutic Apheresis and Dialysis

Volumn 9, Issue 2, 2005, Pages 148-153

  Hickstein, Heiko ^a   Külz, Thomas ^a   Claus, Renate ^a   Stange, Jan ^a   Schmidt, Reinhard ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Congenital; Heart block; Immunoadsorption; Plasmapheresis; Pregnancy

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G; RO ANTIBODY;

ADULT; ANTIBODY TITER; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; AUTOIMMUNE DISEASE; CASE REPORT; CONFERENCE PAPER; CONGENITAL HEART BLOCK; DISEASE COURSE; FEMALE; FETUS DEATH; FETUS HYDROPS; HUMAN; IMMUNOADSORPTION; MYOCARDITIS; OUTPATIENT; PLASMAPHERESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

ADSORPTION; ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CARDIOVASCULAR ABNORMALITIES; FEMALE; FETUS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GERMANY; GESTATIONAL AGE; HEART BLOCK; HEMODYNAMIC PROCESSES; HUMANS; IMMUNOSORBENT TECHNIQUES; PREGNANCY; TREATMENT OUTCOME;

EID: 19544384131     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1774-9987.2005.00226.x     Document Type: Conference Paper

References (15)

1. Michaelsson M, Engle MA. Congenital complete heart block: An international study of the natural history. Cardiovasc Clin 1972;4:85-101.
2. Eftekhari P, Salle L, Lezoualc'h F et al. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol 2000;30:2782-90.
3. Miranda-Carus ME, Boutjdir M, Tseng CE, DiDonato F, Chan EK, Buyon JP. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J Immunol 1998;161:5886-92.
4. Buyon JP, Hiebert R, Copel J et al. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
5. Buyon JP, Waltuck J, Kleinman C, Copel J. In utero identification and therapy of congenital heart block. Lupus 1995;4:116-21.
6. Yamada H, Kato EH, Ebina Y et al. Foetal treatment of congenital heart block ascribed to anti-SSA antibody: Case reports with observation of cardiohemodynamics and review of the literature. Am J Reprod Immunol 1999;42: 226-32.
7. van der Leij JN, Visser GH, Bink-Boelkens MT, Meilof JF, Kallenberg CG. Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis. Prenat Diagn 1994;14:1003-7.
8. Feist E, Dorner T, Wagenmann A et al. Successful therapeutic management of risk pregnancy in primary Sjögren syndrome with plasmapheresis and dexamethasone. Z Rheumatol 1996;55:127-32.
9. Hakim RM, Milford E, Himmelfarb J, Wingard R, Lazarus JM, Watt RM. Extracorporeal removal of HLA-antibodies in transplant candidates. Am J Kidney Dis 1990;XVI:423-31.
10. Braun N, Gutenberger S, Nicuolo AD, Guagnin M, Erley CM, Risler T. Einsatz der Immunadsorption zur Therapie der Glomerulonephritis. Nieren- und Hochdruckkrankheiten 1997;26: 370. (in German)
11. Korach JM, Guillevin L, Petitpas D, Berger P, Chillet P. Apheresis registry in France: Indications, techniques, and complications. French Registry Study Group. Ther Apher 2000;4:207-10.
12. Courier D, Weinstein R. Complications of therapeutic plasma exchange: A recent assessment. J Clin Apheresis 1994;9:1-5.
13. Braun N, Gutenberger S, Erley CM, Risler T. Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose. Transfus Sci 1998;19:25-31.
14. Buyon JP, Kim MY, Copel JA, Friedman DM. Anti-Ro/SSA antibodies and congenital heart block: Necessary but not sufficient. Arthritis Rheum 2001;44:1723-7.
15. Moak JP, Barron KS, Hougen TJ et al. Congenital heart block: Development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001;37:238-42.